MLchartDataset catalogue

Angiozyme

Term · Oncology and biomedicine · MLC-T-ONC-000549

A substance being studied in the treatment of cancer. Angiozyme is a special type of RNA made in the laboratory. It stops a protein called vascular endothelial growth factor receptor (VEGFR) from being made. This may prevent the growth of new blood vessels that tumors need to grow. It is a type of angiogenesis inhibitor and a type of ribozyme. Also called RPI.4610.

Table 1. Record
IdentifierMLC-T-ONC-000549
FieldOncology and biomedicine
SynonymsRPI.4610
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-000549",
  "term": "Angiozyme",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of cancer. Angiozyme is a special type of RNA made in the laboratory. It stops a protein called vascular endothelial growth factor receptor (VEGFR) from being made. This may prevent the growth of new blood vessels that tumors need to grow. It is a type of angiogenesis inhibitor and a type of ribozyme. Also called RPI.4610.",
  "synonyms": [
    "RPI.4610"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/angiozyme/"
}

Record 1,128 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.